Extracorporeal therapies in sepsis: a comprehensive review of the Selective Cytopheretic Device, Polymyxin B and Seraph cartridges
Sepsis, a dysregulated host response to infection, is a leading cause of morbidity and mortality in critically ill patients, despite advancements in antimicrobial therapies. Recent innovations in extracorporeal blood purification therapies, such as the Selective Cytopheretic Device (SCD), Polymyxin...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Assuntos: | |
| Acceso en liña: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2459349 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|